(US) Select Premarket Movers Upside:-RTI +42% (being acquired by AA for $42/sh)-PNK +25% (received offer from GLPI to acquire real estate assets)-RMGN +14% (prelim earnings)-OPXA +11% (modified agreement with Merck Serono and received additional $3M payment to support ongoing development of Tcelna)-WLL +11% (reportedly seeking to sell itself following recent decline in oil)-CTIC +8% (announced positive results from Phase 3 Persist-1 trial of pacritinib)-MOBI +4.6% (earnings)-MAC +4.5% (SPG confirms offer to acquire company at $91/shr)-WUBA +4.2% (acquired minority stake in interior decoration service platform To8to)-GLPI +3.7% (offered to acquire PNK's real estate assets)-GM +2.8% (Wilson withdrew nomination to stand for election to Board)-HZNP +2.7% (pre-clinical data with interferon gamma showed improved signs of disease severity of rare bone disease)-AAPL +1% (Watch event)Downside:-ACRX -41% (regulatory update on Zalviso)-AA -4% (acquiring RTI for $41/sh)-MCD -1% (Feb sales)-LEN -1% (negative broker commentary)-TSLA -0.2% (spokesperson says brand remains strong in China but that personnel changes would be made in China) Related ( MOVERSX ) - Source TradeTheNews.com
(US) Select Premarket Movers
Fri, 06 Mar 2015 9:21 AM EST
Upside:
-AVEO +17% (earnings & announcement of Phase 2 results Tivozanib)
-LTM +14% (premarket strength attributed to LBO speculation)
-YY +9% (earnings)
-MSO +8% (earnings)
-SKUL +7% (earnings)
-FNSR +6% (earnings)
-FL +5.2% (earnings)
-TFM +4.7% (earnings)
-THO +3.5% (earnings)
-BAC +2.5% (stress test results; C also up marginally)
-AA +2% (announced strategic review of smelting & refining capacity)
-BIG +2% (earnings)
-AAPL +1.5% (joining the DJIA 3/18, replacing T)
-MRVL +1.3% (positive broker commentary)
Downside:
-SSH -30% (update on US study of C-Pulse Heart Assist System)
-OREX -16% (top FDA official says Contrave data showing heart benefit are unreliable)
-CKP -15% (earnings)
-GENE -14.5% (announced A$18.6M capital raise)
-LULU -3.5% (negative broker commentary)
-SPLS -2.2% (earnings)
-GPS -1.5% (Fed SSS)
-ZION -1.5% (stress test results)
-GS -1.4% (stress test results)
-T -1% (being replaced on the DJIA by AAPL)
-ITCI -1% (priced 4.75M shares at $24/shr)
(US) Select Premarket Movers
Thu, 05 Mar 2015 9:19 AM EST
Upside:
-KYTH +25% (FDA staff notes show ATX-101 presents a consistent & favorable safety profile)
-BIOL +22% (earnings)
-EYES +20% (first successful implantation of the Argus II retinal prosthesis system)
-MVIS +14% (licensed PicoP display tech to Fortune Global 100 partner)
-CLDN +14% (initiated with Buy at Roth; expected to announce pivotal trial results from CUPID-2 trial in April '15)
-ARWR +11% (acquired NVS's RNAi R&D portfolio)
-TEAR +11% (announced $35M term loan agreement with CRG)
-PCYC +10% (being acquired by ABBV)
-VSLR +8.5% (earnings)
-MAC +7.3% (SPG said to have made takeover approach)
-MLR +7% (earnings)
-GDOT +6.3% (raised to Outperform from Neutral by Credit Suisse)
-KR +5.3% (earnings)
-RNDY +5.7% (earnings)
- CSIQ +5% (earnings, to form YieldCo)
-MBLY +4.4% (hearing strength attributed to introduction of the 4th generation system-on-chip the Eye4 engineering samples of EyeQ4 expected by Q4 FY15)
-MNK +2.4% (expands hospitals growth platform with Ikaria)
-COST +2.3% (earnings)
-HRTG +2% (earnings)
-SPG +0.8% (said to have made takeover offer for MAC)
Downside:
-ERJ -14% (earnings and FCF may be negative in FY15 due to heavy investment spending)
-VNDA -7% (announced Tradipitant Phase 2 proof of concept study results)
-JOY -6.7% (earnings)
-ABBV -6% (acquiring PCYC)
-HRB -4.3% (earnings)
-ACHN -4% (earnings)
-ARI -3.8% (offering 10M shares of common stock)
-DRII -3.2% (upsized offering to 6.7M share priced at $33.75/shr)
-HTLD -1% (priced 3.25M shares at $23.75/shr)
-GD -0.3% (increased dividend 11%)
Кто знает, как научиться чтению ленты с нуля, поделитесь, случайно нашел, помоему, толковое видео по азам ленты: https://www.youtube.com/watch?v=-DEf4SiVIlo&list=PLVlj1ZByaQmgNbRRtKyPw60Ac_0WnFvMy
В открытом доступе есть чтение ленты от Алексея Маркова, там уже 11 видеоуроков общей продолжительностью около 3 часов, и еще будут в еженедельном обзоре Trading Floor
2savageflyer: не думаю, что VWAP настолько сильный индикатор, чтобы на его основании вообще куда-то заходить, особенно на опене. По факту на минутке видно консолидацию 75.25 - 75 между 9.35 и 9.40. То-есть когда акция окажется ниже чем 75, а вернее ниже 74.90, то можно искать точку на продажу.
Я тоже был в BBBY.
Всё стало ясно куда пойдёт после свечки в 9:36 (лоу 74,92). Так получилось, что вошел по 74,75. Входил 1 лотом, т.к. первоначальный стоп был великоват, потом подтянул за хай свечки в 9:40 (74,76). Так и сидел с ним - ждал отката на добавку. Но цена пёрла ровно и уверенно. На Дневке у акции просматривался уровень поддержки (цель) 72,50, где я её и ждал. После отката затупил/не добавился. Далее тренд стал замедляться. Выставил Buy Limit 72.60 и Buy Stop 73.40. По мере падения цены стал трейлить Стоп за локальные хаи. Макс "требовал" уже крыться. Первым сработал Стоп. Больше не входил - эмоции зашкаливали.
В итоге цена дошла до Цели, но после второго отката.
Всё-равно получилось неплохо! =)
Геп вниз? у них отчет вчера вышел 1.23 при ожидании 1.19 вроде как хорошо но с негативным прогнозом.... я ее во вчерашний список включил по выборке - доходы и дивиденды (отчет по закрытию). Сегодня будут отчеты BBEP, DGX, GBCI, INFY, SYRG - из ликвидных